<DOC>
	<DOCNO>NCT02082340</DOCNO>
	<brief_summary>Randomized trial test effectiveness self-administered drug intake empower TB patient - supervise trained family member support medical counseling reminder - improve treatment adherence treatment success rate , thereby forestall TB MDR-TB epidemic .</brief_summary>
	<brief_title>Innovative Approach Tuberculosis Care Armenia</brief_title>
	<detailed_description>The innovative treatment approach integrate several educational , technological , social evidence-based component . The aim study pilot innovative approach drug-sensitive TB patient outpatient phase tuberculosis treatment . To test effectiveness innovative approach ( intervention ) randomize control trial two arm conduct . The intervention arm include drug-sensitive tuberculosis patient treat accord innovative approach , include self-administered drug intake supervise family member , TB patient family member training ( include distribution leaflet TB ) psychological counseling , reminder text message TB patient , reminder phone call TB patient family member . The control arm include drug-sensitive tuberculosis patient receive regular Directly Observed Therapy recommend World Health Organization .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>Diagnosis drugsensitive TB Age 18 year old Understanding reading Armenian Completion intensive treatment phase Involvement Home Based TB Treatment Program National TB Control Office</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Tuberculosis</keyword>
	<keyword>Armenia</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Directly Observed Therapy ( DOT )</keyword>
	<keyword>Self-administered drug intake</keyword>
</DOC>